NASDAQ:PLXS - Plexus Stock Price, Price Target & More

Plexus trades on the NASDAQ under the ticker symbol "PLXS."

Plexus declared that its Board of Directors has approved a stock buyback plan on Wednesday, February 21st 2018, which authorizes the company to repurchase $200,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Shares repurchase plans are often a sign that the company's leadership believes its stock is undervalued.

Plexus Corp. (NASDAQ:PLXS) released its quarterly earnings data on Wednesday, April, 25th. The technology company reported $0.74 earnings per share (EPS) for the quarter, meeting the Zacks' consensus estimate of $0.74. The technology company earned $699 million during the quarter, compared to the consensus estimate of $691.05 million. Plexus had a positive return on equity of 10.96% and a negative net margin of 1.19%. The company's revenue was up 15.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.84 earnings per share. View Plexus' Earnings History.

Plexus is scheduled to release their next quarterly earnings announcement on Wednesday, July, 18th 2018. View Earnings Estimates for Plexus.

Plexus issued an update on its third quarter earnings guidance on Wednesday, April, 25th. The company provided EPS guidance of $0.76-0.86 for the period, compared to the Thomson Reuters consensus estimate of $0.87. The company issued revenue guidance of $700-740 million, compared to the consensus revenue estimate of $710.67 million.

5 analysts have issued 12-month price targets for Plexus' shares. Their predictions range from $54.00 to $70.00. On average, they expect Plexus' stock price to reach $60.75 in the next twelve months. View Analyst Ratings for Plexus.

Plexus saw a increase in short interest during the month of May. As of May 15th, there was short interest totalling 1,078,003 shares, an increase of 51.7% from the April 30th total of 710,382 shares. Based on an average daily volume of 200,317 shares, the days-to-cover ratio is presently 5.4 days. Approximately 3.3% of the company's shares are sold short. View Plexus' Current Options Chain.

Some companies that are related to Plexus include Flex (FLEX), Jabil (JBL), Sanmina (SANM), TTM Technologies (TTMI), Celestica (CLS), Benchmark Electronics (BHE), CTS (CTS), Kimball Electronics (KE), Park Electrochemical (PKE), Sparton (SPA), SMTC (SMTX), NANO DIMENSION/S (NNDM), IEC Electronics (IEC), SigmaTron International (SGMA) and Eltek (ELTK).

News headlines about PLXS stock have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group ranks the sentiment of media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Plexus earned a daily sentiment score of 0.19 on Accern's scale. They also assigned media coverage about the technology company an impact score of 46.86 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Plexus' stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (13.17%), Disciplined Growth Investors Inc. MN (8.89%), Dimensional Fund Advisors LP (8.50%), Barrow Hanley Mewhinney & Strauss LLC (4.37%), Franklin Resources Inc. (3.70%) and Northern Trust Corp (3.11%). Company insiders that own Plexus stock include Angelo Michael Ninivaggi Jr, David J Drury, Dean A Foate, Michael V Schrock, Oliver K Mihm, Patrick John Jermain, Peter Kelly, Ralf R Boer, Ronnie Darroch, Stephen P Cortinovis, Steven J Frisch, Todd P Kelsey and Yong Jin Lim. View Institutional Ownership Trends for Plexus.

PLXS stock was sold by a variety of institutional investors in the last quarter, including American Century Companies Inc., Disciplined Growth Investors Inc. MN, Massachusetts Financial Services Co. MA, JPMorgan Chase & Co., Vaughan Nelson Investment Management L.P., Citigroup Inc., Barrow Hanley Mewhinney & Strauss LLC and Royal Bank of Canada. Company insiders that have sold Plexus company stock in the last year include Angelo Michael Ninivaggi Jr, David J Drury, Dean A Foate, Michael V Schrock, Oliver K Mihm, Patrick John Jermain, Ralf R Boer, Ronnie Darroch, Stephen P Cortinovis, Steven J Frisch, Todd P Kelsey and Yong Jin Lim. View Insider Buying and Selling for Plexus.

PLXS stock was purchased by a variety of institutional investors in the last quarter, including Thrivent Financial for Lutherans, Cooke & Bieler LP, Silvercrest Asset Management Group LLC, Scout Investments Inc., Carillon Tower Advisers Inc., BlackRock Inc., Dean Investment Associates LLC and Franklin Resources Inc.. View Insider Buying and Selling for Plexus.

Shares of PLXS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of PLXS stock can currently be purchased for approximately $61.46.

Plexus has a market capitalization of $2.01 billion and generates $2.53 billion in revenue each year. The technology company earns $112.06 million in net income (profit) each year or $3.24 on an earnings per share basis. Plexus employs 16,000 workers across the globe.

Plexus' mailing address is One Plexus Way, Neenah WI, 54957. The technology company can be reached via phone at 920-969-6000 or via email at [email protected]